AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Investigation Continues: RxSight Investors Urged to Contact Glancy Prongay & Murray LLP
ByAinvest
Wednesday, Jul 16, 2025 1:05 pm ET1min read
Glancy Prongay & Murray LLP is investigating RxSight, Inc. (NASDAQ: RXST) for possible securities law violations. On July 9, 2025, the company reported significant declines in sales and revenue, leading to a 37.8% stock price drop. Investors who lost money are urged to contact Glancy Prongay & Murray LLP to inquire about potentially pursuing claims to recover their losses.
July 2, 2025Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, has announced it is investigating RxSight, Inc. (NASDAQ: RXST) for possible securities law violations. The investigation comes on the heels of significant declines in the company's sales and revenue, which led to a substantial drop in its stock price.
On July 9, 2025, RxSight reported preliminary second quarter 2025 financial results, revealing significant declines in Light Delivery Devices (LDD) sales, light adjustable intraocular lenses (LAL) utilization, and overall revenue. The company also lowered its full-year 2025 guidance by approximately $42.5 million at the midpoint, citing "adoption challenges over the last few quarters" as a primary reason for the LDD stall [4].
Following the announcement, RxSight's stock price fell by $4.84, or 37.8%, closing at $7.95 per share on July 9, 2025. This significant drop has injured investors who are now urged to contact Glancy Prongay & Murray LLP to inquire about potentially pursuing claims to recover their losses.
Investors who have lost money on RxSight, Inc. (RXST) are encouraged to contact the law firm for more information about their rights. Glancy Prongay & Murray LLP's investigation aims to determine whether RxSight, Inc. violated federal securities laws and breached fiduciary duties to shareholders.
References:
[1] https://www.tradingview.com/news/reuters.com,2025-07-15:newsml_GNX4CrNLD:0-robbins-llp-is-investigating-the-officers-and-directors-of-rxsight-inc-rxst-to-determine-if-they-breached-fiduciary-duties-owed-to-shareholders/
[2] https://www.businesswire.com/news/home/20250710908620/en/Securities-Fraud-Investigation-Into-National-Grid-plc-NGG-Announced-Investors-Who-Lost-Money-Urged-To-Contact-Glancy-Prongay-Murray-LLP-a-Leading-Securities-Fraud-Law-Firm
[3] https://www.morningstar.com/news/business-wire/20250710908620/securities-fraud-investigation-into-national-grid-plc-ngg-announced-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-a-leading-securities-fraud-law-firm
[4] https://www.businesswire.com/news/home/20250716511960/en/Securities-Fraud-Investigation-Into-RxSight-Inc.-RXST-Continues-Investors-Who-Lost-Money-Urged-To-Contact-Glancy-Prongay-Murray-LLP-a-Leading-Securities-Fraud-Law-Firm
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet